ArticleScientific reports2025
A novel fibronectin-binding peptide reveals dynamic intermediate structures during matrix assembly.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The extracellular matrix (ECM) is an expansive network of polymers that regulates cell adhesion, migration, and tissue morphogenesis, and that becomes dysregulated in fibrotic disease states. Of the many ECM proteins, fibronectin (FN) is foundational and FN fibrils are instrumental in promoting deposition of many other ECM proteins. FN fibrils form by cell receptor-mediated polymerization of secreted FN dimers. To provide a deeper understanding of the FN assembly process, we sought to identify FN-binding peptides that could be used to target FN during matrix assembly. Here we report the isolation of a FN-binding peptide, S2, by M13 phage display. When displayed within a GST-S2-EGFP fusion protein, S2 directs incorporation of the fluorescent fusion protein into FN fibrils during fibroblast matrix assembly, enabling direct visualization of fibril formation and accumulation. The S2 fusion protein remains stably associated with FN in decellularized matrices. Live cell imaging with GST-S2-EGFP revealed events in matrix formation and maturation and highlighted distinct features of FN assembly such as nascent fibril nucleation and elongation from coalescing FN aggregates. This S2 peptide fusion protein represents a new tool for real-time analysis of the ECM, for generation of fluorescent scaffolds, and for directing functional proteins to FN matrix.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.